Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency

International Orthopaedics

Volumn 35, Issue 11, 2011, Pages 1633-1637

  Streich, Nikolaus A ^a   Zimmermann, David ^a   Schmitt, Holger ^a   Bode, Gerrit ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C TERMINAL TELOPEPTIDE I; C TERMINAL TELOPEPTIDE II; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICLE; BONE TURNOVER; CARTILAGE; CHONDROPATHY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; VOLUMETRY;

ADULT; ANTERIOR CRUCIATE LIGAMENT; BIOLOGICAL MARKERS; COLLAGEN TYPE I; COLLAGEN TYPE II; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; KNEE INJURIES; KNEE JOINT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOGENESIS; PEPTIDES; RUPTURE;

EID: 80755136608     PISSN: 03412695     EISSN: 14325195     Source Type: Journal    
DOI: 10.1007/s00264-010-1191-5     Document Type: Article

References (23)

1. IF Petersson LT Jacobsson 2002 Osteoarthritis of the peripheral joints Best Pract Res Clin Rheumatol 16 741 760 12473271 10.1053/berh.2002.0266
2. JR Kirwan CJ Elson 2000 Is the progression of osteoarthritis phasic? Evidence and implications J Rheumatol 27 834 836 10782803 1:STN:280: DC%2BD3c3kt1yqtQ%3D%3D (Pubitemid 30389734)
3. E Vignon P Garnero P Delmas B Avouac P Bettica M Boers E Ehrich N MacKillop L Rovati U Serni, et al. 2001 Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers Osteoarthritis Cartilage 9 289 293 11403034 10.1053/joca.2000.0387 1:STN:280:DC%2BD3MzjsVKlsA%3D%3D (Pubitemid 32454771)
4. P Garnero JC Rousseau PD Delmas 2000 Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases Arthritis Rheum 43 953 968 10817547 10.1002/1529-0131(200005)43:5<953::AID-ANR1>3. 0.CO;2-Q 1:CAS:528:DC%2BD3cXjvVeitbo%3D (Pubitemid 30368171)
5. O Bruyere J Collette M Kothari S Zaim D White HK Genant C Peterfy N Burlet D Ethgen T Montague, et al. 2006 Osteoarthritis, magnetic resonance imaging and biochemical markers: a one-year prospective study Ann Rheum Dis 65 1050 1054 16396978 10.1136/ard.2005.045914 1:STN:280:DC%2BD28vhsFartQ%3D%3D (Pubitemid 44133268)
6. Y Wang PR Ebeling F Hanna R O'Sullivan FM Cicuttini 2005 Relationship between bone markers and knee cartilage volume in healthy men J Rheumatol 32 2200 2204 16265703 1:CAS:528:DC%2BD2MXht12ltbjO (Pubitemid 41587868)
7. P Garnero 2006 Use of biochemical markers to study and follow patients with osteoarthritis Curr Rheumatol Rep 8 37 44 16515763 10.1007/s11926-006-0023- 5 (Pubitemid 44659358)
8. P Bettica G Cline DJ Hart J Meyer TD Spector 2002 Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study Arthritis Rheum 46 3178 3184 12483721 10.1002/art.10630 (Pubitemid 35453526)
9. M Hudelmaier C Glaser KH Englmeier M Reiser R Putz F Eckstein 2003 Correlation of knee-joint cartilage morphology with muscle cross-sectional areas vs. anthropometric variables Anat Rec A Discov Mol Cell Evol Biol 270 175 184 12524692 10.1002/ar.a.10001 (Pubitemid 37238374)
10. SJ Gandy PA Dieppe MC Keen RA Maciewicz I Watt JC Waterton 2002 No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging Osteoarthritis Cartilage 10 929 937 12464553 10.1053/joca.2002.0849 1:STN:280:DC%2BD38jgtleksQ%3D%3D (Pubitemid 35439418)
11. P Garnero M Piperno E Gineyts S Christgau PD Delmas E Vignon 2001 Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage Ann Rheum Dis 60 619 626 11350852 10.1136/ard.60.6.619 1:CAS:528:DC%2BD3MXksVyhtrY%3D (Pubitemid 32493990)
12. P Garnero R Landewe M Boers A Verhoeven S Van Der Linden S Christgau D Van Der Heijde A Boonen P Geusens 2002 Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study Arthritis Rheum 46 2847 2856 12428224 10.1002/art.10616 1:CAS:528:DC%2BD38XptlSlu7c%3D (Pubitemid 35315875)
13. M Takahashi M Suzuki K Naitou S Miyamoto K Kushida 1999 Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis Rheumatology (Oxford) 38 133 138 10.1093/rheumatology/38.2.133 1:STN:280:DyaK1M3nt1SmsQ%3D%3D (Pubitemid 29507233)
14. P Garnero B Mazieres A Gueguen M Abbal L Berdah M Lequesne M Nguyen JP Salles E Vignon M Dougados 2005 Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort J Rheumatol 32 697 703 15801028 1:CAS:528:DC%2BD2MXjvVymtr0%3D (Pubitemid 40524704)
15. CR Davis J Karl R Granell JR Kirwan J Fasham J Johansen P Garnero M Sharif 2005 Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 56 4038 4047 10.1002/art.23129 (Pubitemid 350262331)
16. S Christgau P Garnero C Fledelius C Moniz M Ensig E Gineyts C Rosenquist P Qvist 2001 Collagen type II C-telopeptide fragments as an index of cartilage degradation Bone 29 209 215 11557363 10.1016/S8756-3282(01)00504-X 1:CAS:528:DC%2BD3MXms12ksb4%3D (Pubitemid 32823562)
17. M Reijman JM Hazes SM Bierma-Zeinstra BW Koes S Christgau C Christiansen AG Uitterlinden HA Pols 2004 A new marker for osteoarthritis: cross-sectional and longitudinal approach Arthritis Rheum 50 2471 2478 15334460 10.1002/art.20332 1:CAS:528:DC%2BD2cXnsVKhtrg%3D (Pubitemid 39062707)
18. KM Jordan HE Syddall P Garnero E Gineyts EM Dennison AA Sayer PD Delmas C Cooper NK Arden 2006 Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men Ann Rheum Dis 65 871 877 16284096 10.1136/ard.2005.042895 1:CAS:528:DC%2BD28XntF2lsr4%3D
19. M Sharif J Kirwan N Charni LJ Sandell C Whittles P Garnero 2007 A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression Rheumatology (Oxford) 46 938 943 10.1093/rheumatology/kel409 1:CAS:528:DC%2BD2sXot1Sgsbk%3D (Pubitemid 47062500)
20. AD Recklies L Baillargeon C White 1998 Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes Arthritis Rheum 41 997 1006 9627009 10.1002/1529-0131(199806)41:6<997::AID- ART6>3.0.CO;2-G 1:CAS:528:DyaK1cXktVCjsLY%3D (Pubitemid 28265402)
21. RK Smith L Zunino PM Webbon D Heinegard 1997 The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load Matrix Biol 16 255 271 9501326 10.1016/S0945-053X(97) 90014-7 1:CAS:528:DyaK2sXnslaitrk%3D (Pubitemid 27503812)
22. M Neidhart N Hauser M Paulsson PE DiCesare BA Michel HJ Hauselmann 1997 Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation Br J Rheumatol 36 1151 1160 9402858 10.1093/rheumatology/36.11.1151 1:CAS:528:DyaK1cXltFan
23. M Jung S Christgau M Lukoschek D Henriksen W Richter 2004 Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis Pathobiology 71 70 76 14707441 10.1159/000074419 1:CAS:528:DC%2BD2cXhtV2qsQ%3D%3D (Pubitemid 38056726)